Advertisement
argenx SE

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

ARGXNASDAQ
HealthcareBiotechnology
$898.43
$16.02(1.82%)
U.S. Market is Open · 14:08
Advertisement

argenx SE (ARGX)

Meyka AI Score

Z

Key Financials

Market Cap54.7B
P/E Ratio22.75
EPS (TTM)$22.51
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.75 and a market capitalization of 54.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.47%
5-Day Change
1.82%
1-Month Change
10.23%
3-Month Change
16.07%
6-Month Change
-3.14%
Year-to-Date (YTD) Change
2.52%
1-Year Change
49.82%
3-Year Change
116.75%
5-Year Change
179.11%
All-Time (Max) Change
3648.61%

Contact Information

31 10 703 8441
Laarderhoogtweg 25, Amsterdam, NaN, 1101EB

Company Facts

15,990 Employees
IPO DateMay 18, 2017
CountryNL
Actively Trading

Frequently Asked Questions